However, gender, which is associated with a difference in muscular mass; tumor burden, which correlates with a faster bevacizumab clearance [17]; or serum glutamic oxaloacetic transaminase (SGOT), indicative of impaired liver function, could also be assessed as covariates. Here, GOT1 is linked to neoplasm.